Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.53 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.53 |
| ▸ | KCNA1 | Q09470 | 1/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.50 |
| ▸ | ATM | Q13315 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tetrylammonium SCHEMBL27667739 | 0.97 | TSHR (0.50) | TSHRNFKB1KCNA1KDM4EPMP22 | |
| Tetrylammonium SCHEMBL5570466 | 0.90 | TSHR (0.57) | TSHRNFKB1KCNA1KDM4EPMP22 | |
| Tetrylammonium SCHEMBL532601 | 0.84 | TSHR (0.50) | TSHRNFKB1KCNA1KDM4EPMP22 | |
| Tetrylammonium SCHEMBL4335116 | 0.76 | TSHR (0.57) | TSHRNFKB1KCNA1KDM4EPMP22 | |
| Tetrylammonium SCHEMBL7570609 | 0.76 | TSHR (0.57) | TSHRNFKB1KCNA1KDM4EPMP22 | |
| Tetrylammonium SCHEMBL2861891 | 0.73 | TSHR (0.80) | TSHRNFKB1KCNA1KDM4EPMP22 | |
| Tetrylammonium SCHEMBL4078612 | 0.73 | TSHR (1.00) | TSHRNFKB1KCNA1KDM4EPMP22 | |
| Tetrylammonium SCHEMBL5484929 | 0.73 | TSHR (1.00) | TSHRNFKB1KCNA1KDM4EPMP22 | |
| Tetrylammonium SCHEMBL16267 | 0.73 | — | — | |
| Tetrylammonium SCHEMBL11352843 | 0.70 | TSHR (0.73) | TSHRNFKB1KCNA1KDM4EPMP22 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12515959-B1 | Method for size-controlled synthesis of transition metal cyanide coordination compound | NATRON ENERGY, INC. (US) | 2026-01-06 | — | — | US | claimed |
| US-12384689-B2 | Low vacancy Fe-substituted Mn-based prussian blue analogue | NATRON ENERGY, INC. (US) | 2025-08-12 | — | — | US | claimed |
| US-20240351897-A1 | MULTIPRODUCT MANUFACTURING METHODS FOR PRUSSIAN BLUE ANALOGUES | NATRON ENERGY, INC. (US) | 2024-10-24 | — | — | US | claimed |
| WO-2024216248-A2 | MULTIPRODUCT MANUFACTURING METHODS FOR PRUSSIAN BLUE ANALOGUES | NATRON ENERGY, INC. (US) | 2024-10-17 | — | — | WO | claimed |
| US-20240343596-A1 | MULTIPRODUCT MANUFACTURING METHODS FOR PRUSSIAN BLUE ANALOGUES | NATRON ENERGY, INC. (US) | 2024-10-17 | — | — | US | claimed |
| WO-2024192157-A2 | LOW VACANCY FE-SUBSTITUTED MN-BASED PRUSSIAN BLUE ANALOGUE | NATRON ENERGY, INC. (US) | 2024-09-19 | — | — | WO | claimed |
| US-20240308862-A1 | LOW VACANCY Fe-SUBSTITUTED Mn-BASED PRUSSIAN BLUE ANALOGUE | NATRON ENERGY, INC. (US) | 2024-09-19 | — | — | US | claimed |
| EP-1682539-B1 | PROCESS FOR PREPARING THIAZOLIDINEDIONES | SANDOZ AG (CH) | 2010-02-24 | — | — | EP | disclosed |
| US-7511148-B2 | Process for preparing thiazolidinediones | SANDOZ AG (CH) | 2009-03-31 | — | — | US | disclosed |
| US-20070276012-A1 | Process for Preparing Thiazolidinediones | SANDOZ AG (CH) | 2007-11-29 | — | — | US | disclosed |
| EP-1682539-A1 | PROCESS FOR PREPARING THIAZOLIDINEDIONES | Sandoz AG (CH) | 2006-07-26 | — | — | EP | disclosed |
| WO-2005049610-A1 | PROCESS FOR PREPARING THIAZOLIDINEDIONES | SANDOZ AG (CH) | 2005-06-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070276012-A1 | Process for Preparing Thiazolidinediones | SLC5A2, NDUFS5, NDUFS4 | TSHR 373/4885NFKB1 2912/4885KCNA1 2861/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.